SUPN
SUPN
US8684591089
Supernus Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 718.952.000 661.817.000
8.6%
Cost of Revenue 74.562.000 77.906.000
4.3%
Gross Profit 644.390.000 583.911.000
10.4%
681.254.000 508.355.000
34.0%
Operating Income -36.864.000 75.556.000
148.8%
Pretax Income -49.030.000 97.870.000
150.1%
Net Income Common Stockholders -38.550.000 73.865.000
152.2%
-- --
--
-- --
--
ende